BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer

Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...

January 11, 2023 | News

Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative's ...

January 11, 2023 | News

Sarepta and Catalent Expand Strategic Manufacturing Partnership

Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, and Sarepta Therapeutics, Inc. (...

January 06, 2023 | News

WuXi STA Launches First Continuous Manufacturing Line for Oral Solids

WuXi STA’s continuous manufacturing line features continuous direct compression equipment with unit operations including dispensing, blending, lubric...

January 04, 2023 | News

Polysciences Announces New Bioprocessing Brand, Kyfora Bio

Building on Polysciences’ extensive experience in developing and manufacturing monomers, polymers, microspheres, and specialty reagents for the medic...

January 03, 2023 | News

GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development

According to the collaboration agreements, WuXi XDC will actively promote GeneQuantum’s proprietary iLDC (intelligent Ligase-dependent Conjugation) a...

December 28, 2022 | News

Cell and Gene Therapy Companies Leverage GenScript's cGMP sgRNA Capability to Accelerate Speed to Market

GenScript USA Inc., the world's leading life-science service provider, recently expanded its global current Good Manufacturing Practices (cGMP)&n...

December 19, 2022 | News

Bio Elpida Acquisition Brings GMP Fill and Finish Capacity to Polyplus

“Bio Elpida is certified by the French Health Authorities (ANSM) as a Pharmaceutical Company to manufacture Active Pharmaceutical Ingredients and Adv...

December 15, 2022 | News

Catalent Opens One of the World’s Largest Commercial-Scale Cell Therapy Manufacturing Facilities

Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient tr...

December 09, 2022 | News

GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS

GenScript ProBio extended congratulations on this. Since December 2019, GenScript ProBio has joined the strategic collaboration with Selecxine for the...

December 07, 2022 | News

WuXi STA Launches Another Parenteral Formulation Manufacturing Line at Wuxi city site

This new line features a fully automatic vial loading/unloading system and a built-in 15 m2 lyophilizer in a fully enclosed isolator. The filling line...

December 01, 2022 | News

Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies

Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three premier medical device manufacturing companies to form an integrate...

November 29, 2022 | News

WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility

WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...

November 24, 2022 | News

Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its cell therapy contract development and manufacturing (C...

November 08, 2022 | News

Stay Connected